FCGR2A and infection: This can cause antibody-dependent enhancement (ADE), in which weakly neutralizing antibodies from the first infection bind to the second serotype and enhance infection of myeloid cells, such as monocytes and macrophages, expressing FcγR, like CD16 expressed by NK cells [100].